Understand Incyte Corp’s commercialized product portfolio to stay one step ahead of the market.
|Drug Name||Generic Name||Brand Name||Company Name||Therapy Area||Indication||Development Stage||Drug Geography|
|Opzelura||ruxolitinib phosphate||Opzelura||Incyte Corp||Dermatology||Atopic Dermatitis (Atopic Eczema)||Marketed||United States|
|pemigatinib||pemigatinib||Pemazyre||Innovent Biologics Inc||Oncology||Metastatic Bile Duct Cancer||Marketed||China|
|pemigatinib||pemigatinib||Pemazyre||Incyte Biosciences UK Ltd||Oncology||Metastatic Bile Duct Cancer||Marketed||United Kingdom|
Marketed Drugs is an integrated platform that provides interactive, comprehensive, and analytical competitive intelligence of Marketed Pharmaceutical Drug information.
Marketed Drugs covers an extensive number of therapy areas and indications across 23 countries. Marketed Drug profiles provide a comprehensive breakdown of information spanning across Drug Details, Marketed Drug Overview (Lifecycle Management, Safety Details and Efficacy Details), Marketing Information (Regulatory Information), Clinical Trials, Sales and Consensus Forecast and Net Present Value.
Keep up-to-date on new Pipeline drug developments and market approvals. Competitive analysis of Marketed drugs.
Marketed Drug data is used prominently to generate a range of premium analytical reports offering unique insight. Seamless integration makes in depth investigation of drugs extremely simple.
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer